Comments
Sun Pharmaceutical Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 29, 2014, inter alia, to consider and approve the audited financial results of the Company stand alone and consolidated for the year ended March 31, 2014. The said audited results are subject to revision so as to give effect of demerger with effect from May 01, 2013 of the Specified Undertaking of Sun Pharma Global FZE, the Companys wholly owned subsidiary company with the Company, after receipt of all required approvals from the statutory authorities in respect of the demerger. Further, note that window closure for Trading by Designated persons as per Insider Trading Rules of the Company will be from May 20, 2014 to June 02, 2014 (both days inclusive).
Source : BSE - >www.bseindia.com
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.